CYTEK BIOSCIENCES, INC. (CTKB) Operating cash flow 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.7MFY2025 · since FY2020: $15.2M → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.7M | -118.5% |
| FY2024 | $25.4M | +380.6% |
| FY2023 | $5.3M | +143.2% |
| FY2022 | -$12.2M | -364.2% |
| FY2021 | $4.6M | -69.5% |
| FY2020 | $15.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTKB financial trends
CTKB RevenueCTKB Net incomeCTKB Net marginCTKB Gross profitCTKB Gross marginCTKB Operating incomeCTKB Operating marginCTKB Free cash flowCTKB Capital expendituresCTKB Return on equityCTKB Stock buybacksCTKB Dividends paidCTKB Total assetsCTKB Total liabilitiesCTKB Shareholders’ equityCTKB overview →